@article{3339680, title = "Prevention of Alzheimer’s Disease and Cognitive Decline with Diet & Lifestyle: Proceedings of the A. G. Leventis Foundation Conference", author = "Hershey, M.S. and Sotos-Prieto, M. and Andrieu, S. and Hofman, A. and Magiatis, P. and Martinez-Gonzalez, M.A. and Yannakoulia, M. and Kales, S.N. and Scarmeas, N.", journal = "JPAD: The Journal of Prevention of Alzheimers Disease", year = "2023", volume = "10", number = "1", pages = "137-143", publisher = "Serdi-Editions", doi = "10.14283/jpad.2022.99", keywords = "nutraceutical; olive oil; polyphenol, Alzheimer disease; Article; cognition; cognitive defect; dementia; diet; dietary pattern; evidence based medicine; healthy diet; human; lifestyle; Mediterranean diet; mediterranean dietary approaches to stop hypertension intervention for neurodegenerative delay diet; nutrition; outcome assessment; prevention and control; public health; Alzheimer disease; cognitive defect; dietary supplement; lifestyle; Mediterranean diet, Alzheimer Disease; Cognitive Dysfunction; Diet, Mediterranean; Dietary Supplements; Humans; Life Style", abstract = "The A. G. Leventis Foundation International Conference, “Prevention of Alzheimer’s Disease and Cognitive Decline with Diet & Lifestyle”, was held on May 11–12th, 2022 in Nicosia, Cyprus. This conference examined the role of diet and lifestyle for the prevention and treatment of Alzheimer’s Disease and other forms of cognitive decline. Speakers from leading academic institutions presented evidence on healthy dietary patterns, with a particular focus on the traditional Mediterranean diet (MedDiet), in association with cognitive outcomes, mainly cognitive decline, dementia, and Alzheimer’s disease, from both observational and interventional studies. Moreover, future directions for the potential use of olive oil, rich in polyphenols, for its therapeutic use as a nutraceutical, as well as nutritional interventions with high-quality dietary patterns (i.e. MedDiet) that support existing primarily observational evidence for the prevention of cognitive decline, as well as challenges in designing rigorous clinical trials are summarized and discussed within the conference proceedings. © 2022, Serdi." }